title: Thailand Diabetic Registry cohort: predicting death in Thai diabetic patients and causes of death.
abstract: BACKGROUND
  The prevalence of type 2 diabetes in Thailand is 9.8 percent which is double the number forecast by World Health Organization. There is inadequate information to statistically represent all Thai diabetic patients for their causes of death.
  
  
  OBJECTIVE
  To determine the clinical characteristics that predicted death and causes of death in Thai diabetic patients.
  
  
  METHODS
  This prospective cohort was a 3-year follow-up study of the Thai Diabetes Registry project done between April, 2003, and February, 2006, which registered 9,419 diabetic patients attending 11 diabetic clinics in tertiary medical centers in Bangkok and major provinces of Thailand. The dead or alive status (99.5%) was determined. The causes of death were defined by reviewing the medical records.
  
  
  RESULTS
  Of the 9,370 diabetic patients registered, 425 patients died, 1.84 percent per year. There was an increased risk of death associated with age, type of healthcare plan, lower education, insulin use, smoking, history of coronary artery disease and cerebrovascular disease, serum creatinine and high HbA1c. Lipid-lowering medication and metformin decreased the risk of death. Cardiovascular disease, infection and cancer were the prevalent causes of death.
  
  
  CONCLUSIONS
  The present study showed risk factors that influenced death and causes of death in Thai diabetics.
authors.affiliation: Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. thongcha@kku.ac.th
authors.forename: Thongchai
authors.initials: T
authors.lastname: Pratipanawatr
authors.forename: Petch
authors.initials: P
authors.lastname: Rawdaree
authors.forename: Thanya
authors.initials: T
authors.lastname: Chetthakul
authors.forename: Pongamorn
authors.initials: P
authors.lastname: Bunnag
authors.forename: Chardpraorn
authors.initials: C
authors.lastname: Ngarmukos
authors.forename: Yupin
authors.initials: Y
authors.lastname: Benjasuratwong
authors.forename: Rattana
authors.initials: R
authors.lastname: Leelawatana
authors.forename: Natapong
authors.initials: N
authors.lastname: Kosachunhanun
authors.forename: Nattachet
authors.initials: N
authors.lastname: Plengvidhya
authors.forename: Chaicharn
authors.initials: C
authors.lastname: Deerochanawong
authors.forename: Sompongse
authors.initials: S
authors.lastname: Suwanwalaikorn
authors.forename: Sirinate
authors.initials: S
authors.lastname: Krittiyawong
authors.forename: Sirima
authors.initials: S
authors.lastname: Mongkolsomlit
authors.forename: Chulaluk
authors.initials: C
authors.lastname: Komoltri
mesh_terms: D000368:Aged; D044466:Asian People; D002318:Cardiovascular Diseases / Q000150:complications / Q000401:mortality*; D002423:Cause of Death; D048909:Diabetes Complications / Q000401:mortality*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000401:mortality* / Q000503:physiopathology; D050171:Dyslipidemias / Q000188:drug therapy / Q000453:epidemiology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007239:Infections / Q000209:etiology / Q000401:mortality; D008297:Male; D008687:Metformin / Q000627:therapeutic use; D008875:Middle Aged; D009369:Neoplasms / Q000209:etiology / Q000401:mortality; D015995:Prevalence; D011446:Prospective Studies; D012042:Registries; D012307:Risk Factors; D013785:Thailand / Q000453:epidemiology
chemical_list: D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents; D008687:Metformin